BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31300881)

  • 1. Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.
    Osman KL; Kohlberg S; Mok A; Brooks R; Lind LA; McCormack K; Ferreira A; Kadosh M; Fagan MK; Bearce E; Nichols NL; Coates JR; Lever TE
    Dysphagia; 2020 Apr; 35(2):343-359. PubMed ID: 31300881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Limb Phenotype on Tongue Denervation Atrophy, Dysphagia Penetrance, and Survival Time in a Mouse Model of ALS.
    Mueller M; Thompson R; Osman KL; Andel E; DeJonge CA; Kington S; Stephenson Z; Hamad A; Bunyak F; Nichols NL; Lever TE
    Dysphagia; 2022 Dec; 37(6):1777-1795. PubMed ID: 35426522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralingual Administration of AAVrh10-miR
    Lind LA; Andel EM; McCall AL; Dhindsa JS; Johnson KA; Stricklin OE; Mueller C; ElMallah MK; Lever TE; Nichols NL
    Hum Gene Ther; 2020 Aug; 31(15-16):828-838. PubMed ID: 32498636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model of oral dysphagia in amyotrophic lateral sclerosis.
    Lever TE; Gorsek A; Cox KT; O'Brien KF; Capra NF; Hough MS; Murashov AK
    Dysphagia; 2009 Jun; 24(2):180-95. PubMed ID: 19107538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to Dysphagia.
    Lind LA; Murphy ER; Lever TE; Nichols NL
    Neuroscience; 2018 Oct; 390():303-316. PubMed ID: 30179644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum Tongue Pressure is Associated with Swallowing Dysfunction in ALS Patients.
    Hiraoka A; Yoshikawa M; Nakamori M; Hosomi N; Nagasaki T; Mori T; Oda M; Maruyama H; Yoshida M; Izumi Y; Matsumoto M; Tsuga K
    Dysphagia; 2017 Aug; 32(4):542-547. PubMed ID: 28424896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tongue strength, dysphagia questionnaire, pharyngeal secretions and FEES findings in dysphagia management in amyotrophic lateral sclerosis.
    Printza A; Boziki M; Triaridis S; Kiousi V; Arnaoutoglou M; Constantinidis J; Grigoriadis N
    Auris Nasus Larynx; 2021 Aug; 48(4):672-682. PubMed ID: 33109427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of pharyngeal dysphagia in amyotrophic lateral sclerosis.
    Lever TE; Simon E; Cox KT; Capra NF; O'Brien KF; Hough MS; Murashov AK
    Dysphagia; 2010 Jun; 25(2):112-26. PubMed ID: 19495873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N
    Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients.
    Nakamori M; Hosomi N; Takaki S; Oda M; Hiraoka A; Yoshikawa M; Matsushima H; Ochi K; Tsuga K; Maruyama H; Izumi Y; Matsumoto M
    Clin Neurophysiol; 2016 Feb; 127(2):1669-1674. PubMed ID: 26323377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis.
    Ma D; Shuler JM; Kumar A; Stanford QR; Tungtur S; Nishimune H; Stanford JA
    Neurorehabil Neural Repair; 2017 Feb; 31(2):147-156. PubMed ID: 27573800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between tongue motility, grip force, and survival in SOD1-G93A rats.
    Smittkamp SE; Spalding HN; Brown JW; Yeh HW; Stanford JA
    Physiol Behav; 2014 Feb; 125():17-20. PubMed ID: 24291387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between maximum tongue pressure and swallowing safety and efficacy in amyotrophic lateral sclerosis.
    Pizzorni N; Ginocchio D; Bianchi F; Feroldi S; Vedrodyova M; Mora G; Schindler A
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13859. PubMed ID: 32337820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.
    Smittkamp SE; Brown JW; Stanford JA
    Neuroscience; 2008 Jan; 151(2):613-21. PubMed ID: 18061359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.